Related references
Note: Only part of the references are listed.Inhibition of NPC1L1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy
Zhe Zhang et al.
EMBO MOLECULAR MEDICINE (2022)
Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis
Joseph Puccini et al.
TRENDS IN CANCER (2022)
Patient-derived xenografts and organoids model therapy response in prostate cancer
Sofia Karkampouna et al.
NATURE COMMUNICATIONS (2021)
Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer
Ran Li et al.
NATURE NANOTECHNOLOGY (2021)
Harnessing metabolic dependencies in pancreatic cancers
Joel Encarnacion-Rosado et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Advances in NAD-Lowering Agents for Cancer Treatment
Moustafa S. Ghanem et al.
NUTRIENTS (2021)
Cancer metabolism: looking forward
Inmaculada Martinez-Reyes et al.
NATURE REVIEWS CANCER (2021)
Macropinocytosis confers resistance to therapies targeting cancer anabolism
Vaishali Jayashankar et al.
NATURE COMMUNICATIONS (2020)
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
Ubaldina Galli et al.
FRONTIERS IN PHARMACOLOGY (2020)
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
Leo Aubert et al.
NATURE COMMUNICATIONS (2020)
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
NAD+metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
NAD(+) homeostasis in health and disease
Elena Katsyuba et al.
NATURE METABOLISM (2020)
NAD+ metabolism governs the proinflammatory senescence-associated secretome
Timothy Nacarelli et al.
NATURE CELL BIOLOGY (2019)
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
Teodora Alexa-Stratulat et al.
DRUG RESISTANCE UPDATES (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
Sayantani Sarkar Bhattacharya et al.
CELL DEATH & DISEASE (2019)
Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells
Ritesh K. Srivastava et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition
Weixuan Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial A Randomized Phase 3 Clinical Trial
Luca Gianni et al.
JAMA ONCOLOGY (2018)
ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition
Weixuan Wang et al.
CELL CHEMICAL BIOLOGY (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
Shawn M. Davidson et al.
NATURE MEDICINE (2017)
Macropinocytosis: A Metabolic Adaptation to nutrient Stress in Cancer
Maria Victoria Recouvreux et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Targeting Metabolism for Cancer Therapy
Alba Luengo et al.
CELL CHEMICAL BIOLOGY (2017)
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair
Francesco Piacente et al.
CANCER RESEARCH (2017)
Toward a Better Understanding of the Complexity of Cancer Drug Resistance
Michael M. Gottesman et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
Carles Canto et al.
CELL METABOLISM (2015)
Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen
Aurelie Mallinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease
Trevor Dale et al.
NATURE CHEMICAL BIOLOGY (2015)
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity
Debora Soncini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Ziyad Binkhathlan et al.
CURRENT CANCER DRUG TARGETS (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The NAD metabolome - a key determinant of cancer cell biology
Alberto Chiarugi et al.
NATURE REVIEWS CANCER (2012)
The P-glycoprotein multidrug transporter
Frances J. Sharom
ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS (2011)
Macropinocytosis: an endocytic pathway for internalising large gulps
Jet Phey Lim et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells
Jean H. Overmeyer et al.
MOLECULAR CANCER (2011)
Sirtuins, Aging, and Medicine
Leonard Guarente
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling
Mirkka Koivusalo et al.
JOURNAL OF CELL BIOLOGY (2010)
Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
D. R. Shepard et al.
JOURNAL OF UROLOGY (2009)
Multiple molecular mechanisms for multidrug resistance transporters
Christopher F. Higgins
NATURE (2007)
Pheophorbide a is a specific probe for ABCG2 function and inhibition
RW Robey et al.
CANCER RESEARCH (2004)
The discovery of ezetimibe: A view from outside the receptor
JW Clader
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
